With the cutoff value set at the median, we found that the mRNA level of CCND1 was not associated with the clinical outcomes of cRCC or pRCC patients (P > 0.05; Figure 4B,D), suggesting CCND1 level is specifically associated with prognosis of ccRCC. The gene discussed is CCND1; the disease is nonpapillary renal cell carcinoma.